Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaymin Morjaria

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Respiratory Medicine|November 18, 2008
Immunomodulatory and biologic therapies for severe refractory asthmaRiccardo Polosa, Jaymin Morjaria
The New England Journal of Medicine|October 14, 2011
Bronchoconstriction and airway remodelingJaymin Morjaria, Simon Hart, Alyn H Morice
Journal of Fungi (Basel, Switzerland)|July 27, 2022
COVID-19-Associated Pulmonary MucormycosisVidya Krishna, Nitin Bansal, Jaymin Morjaria, et al.
Therapeutic Advances in Respiratory Disease|January 14, 2015
Nocardia cyriacigeorgica in an immunocompetent patientSavitri Kibe, Rolf Meigh, Tanya Moon, et al.
Idcases|June 2, 2021
Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infectionVidya Krishna, Jaymin Morjaria, Rona Jalandari, et al.
Internal and Emergency Medicine|December 15, 2017
Biologic agents for severe asthma patients: clinical perspectives and implicationsMassimo Caruso, Jaymin Morjaria, Rosalia Emma, et al.
Therapeutic Advances in Chronic Disease|August 4, 2023
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseasesBeatrice Ragnoli, Alessandro Radaeli, Patrizia Pochetti, et al.
International Journal of Environmental Research and Public Health|May 13, 2014
Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversalRiccardo Polosa, Jaymin Morjaria, Pasquale Caponnetto, et al.
Expert Opinion on Drug Discovery|April 5, 2018
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary diseaseMario Malerba, Alessandro Radaeli, Giuseppe Santini, et al.
Therapeutic Advances in Chronic Disease|June 3, 2022
Dupilumab and tezepelumab in severe refractory asthma: new opportunitiesBeatrice Ragnoli, Jaymin Morjaria, Patrizia Pignatti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Respiratory Medicine|November 18, 2008
Immunomodulatory and biologic therapies for severe refractory asthmaRiccardo Polosa, Jaymin Morjaria
The New England Journal of Medicine|October 14, 2011
Bronchoconstriction and airway remodelingJaymin Morjaria, Simon Hart, Alyn H Morice
Journal of Fungi (Basel, Switzerland)|July 27, 2022
COVID-19-Associated Pulmonary MucormycosisVidya Krishna, Nitin Bansal, Jaymin Morjaria, et al.
Therapeutic Advances in Respiratory Disease|January 14, 2015
Nocardia cyriacigeorgica in an immunocompetent patientSavitri Kibe, Rolf Meigh, Tanya Moon, et al.
Idcases|June 2, 2021
Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infectionVidya Krishna, Jaymin Morjaria, Rona Jalandari, et al.
Internal and Emergency Medicine|December 15, 2017
Biologic agents for severe asthma patients: clinical perspectives and implicationsMassimo Caruso, Jaymin Morjaria, Rosalia Emma, et al.
Therapeutic Advances in Chronic Disease|August 4, 2023
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseasesBeatrice Ragnoli, Alessandro Radaeli, Patrizia Pochetti, et al.
International Journal of Environmental Research and Public Health|May 13, 2014
Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversalRiccardo Polosa, Jaymin Morjaria, Pasquale Caponnetto, et al.
Expert Opinion on Drug Discovery|April 5, 2018
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary diseaseMario Malerba, Alessandro Radaeli, Giuseppe Santini, et al.
Therapeutic Advances in Chronic Disease|June 3, 2022
Dupilumab and tezepelumab in severe refractory asthma: new opportunitiesBeatrice Ragnoli, Jaymin Morjaria, Patrizia Pignatti, et al.
Pageof 2